New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
12:10 EDTSNYFDA discloses ANDA submission with Paragraph IV for Sanofi's Multaq
The FDA disclosed on its website that an Abbreviated New Drug Application was received by the Office of Generic Drugs containing a "Paragraph IV" patent certification for Multaq, a drug marketed by Sanofi-Aventis. The FDA listed a date of submission for the ANDA of July 1, 2013. Reference Link
News For SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
11:19 EDTSNYSanofi reportedly ready to make acquisitions in animal medicine, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use